More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
November 2018
Process Economics of Cell Harvesting Technologies

Biotech | Pall Corporation webinar series

  • The advantages and disadvantages of depth filtration vs cake filtration vs acoustic separation
  • Which process parameters affect the performance of each technology
  • How to identify the most suitable cell harvesting technology for your process

Which cell culture harvesting technology to use in a monoclonal antibody (mAb) process is decided early in process development and as each cell culture has unique characteristics, it is important that process developers have enough information to choose the right technology at this early stage. In this webinar the three most important cell culture harvesting platforms are described and compared on a technical, ease of handling and cost basis. The criteria to choose the best fit technology to get the strongest performing harvest process are explained.

This webcast is being offered twice. Please select the webcast that is best for your time zone.

  • Accelerate time to market for adenovirus manufacturing
  • Design the process for scalability
  • Reduce downstream processing time from 3-4 days to 1 day

With several recent FDA approvals and a strong drug pipeline, the gene therapy market is coming of age and providing new hope for patients. As demand for these new therapies increases, a robust and scalable manufacturing process is critical. In this webinar, we will present an end user case study which illustrates the challenges and solutions to scale both the upstream and downstream process steps required to manufacture adenoviruses.


This webcast is being offered twice. Please select the webcast that is best for your time zone.

June 2018
Driving Quality and Responsiveness in Single- Use Technologies

Biotech | Pall Corporation webinar series

Single-use technologies require a shift of responsibility from biomanufacturers to suppliers to enable production of safe and reliable drugs. One of the pre-requisites for efficient supply is to have standardized processes to design and manufacture single-use systems. We have developed a unique design, quality and business tool to drive quality and responsiveness, and to support standardization of single-use technologies.

Dr Hélène Pora will take you through the functionalities of this system and demonstrate what benefits it brings to end users when implementing single-use technologies in a regulated environment.

April 2018
Ensure Integrity of Your Single-Use Systems

Biotech | Pall Corporation webinar series

In this 45-minute webinar, experts from Pall Biotech will discuss the approach and strategy to ensure the highest level of assurance of integrity of SUS in drug substances and drug products processes. They will take into account the life cycle of the SUS; from its manufacturing to end user’s deployment and use.


You will learn about:


  • The industry trends and recommended approach for the assurance of integrity of single-use systems
  • Available solutions for the highest level of assurance of integrity of SUS
  • A new integrity test for Allegro 2D biocontainer assemblies


Hélène PORA (moderator) - Vice President Technical Communication & Regulatory Strategy, Pall Biotech.


Hélène leads the technical training and regulatory documentation support within Biotech. She has been instrumental in the development of Pall single-use technologies for the last 20 years, while getting heavily involved in quality and regulatory aspects.

She has over 30 years of experience working for the biopharmaceutical industry, the last 27 years within Pall.



Nathalie PATHIER (speaker) - Global Product Manager for Single-Use Technologies, Pall Biotech.


Nathalie has more than 25 years of experience working on bioprocessing. She joined Pall as a Marketing Manager in 2004 and has been dealing with product management in tangential flow filtration and single-use systems since 2009.

She was previously Project Manager in the biopharmaceutical industry where she designed and implemented engineered process solutions for downstream processing.



March 2018

The BPOG Leachables Working Group has recently published a Best Practice guide for Leachables. It was developed to help biopharmaceutical and vaccines manufacturers to develop science-based, robust, and efficient approaches to handling the risk of leachable compounds that is associated with increasing use of single-use systems in manufacturing processes. The Best Practice guide is composed of three parts:

  • the risk assessment model
  • leachable study design
  • analytical methods

This webinar provides insight into the application of the best practices for leachables study design by end users, and will include a case study to highlight the importance of the study design.

Advances in Aseptic Single-Use Fluid Handling and Management

Biotech | Pall Corporation webinar series

Single-use technology has established itself as an integral part of the biomanufacturing process - helping to preserve space, increase flexibility, and save money. Thoughtful design for the handling and transfer of sterile liquids is a key consideration when designing single-use systems, and advances in equipment such as sterile connectors have facilitated many of these operations.  Assuring aseptic connections are reproducible and sterility is maintained during fluid transfer is underpinned by the design, materials of construction, and in-built quality of the connector. In addition, assessing the risk posed by leachables, which are potentially present in final drug product, is a regulatory requirement of biopharmaceutical manufacturers. Key to understanding the risk posed by leachables from single-use connectors is data based on agreed test methods, such as BPOG, that enables end users to make informed decisions on patient safety.

This webinar will explore Pall’s approach to incorporating user requirements in developing the Kleenpak® Presto sterile connector, the next generation genderless sterile connection technology for aseptic fluid handling and management in single-use biopharmaceutical manufacturing. 

A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.

February 2018

Following recent mainstream media coverage of reported supply and demand mismatch, viral vectors now dominate much of the discussion within the cell and gene therapy sector. This panel webinar will provide insight from three leading experts at the forefront of vector manufacturing, as they share first-hand experiences in moving to commercial-scale manufacture of viral vectors.

November 2017

The Cadence™ Virus Inactivation (VI) system, a fully automated low pH virus inactivation system for both batch and continuous processing is one of the latest additions to Pall’s Continuous platform.  This webinar will discuss how traditional low pH virus inactivation has been translated into an automatic system, and also the additional challenges associated with making it a continuous process.  There will be a review of the two methods used for validating the design and an overview of the integration of capture chromatography and virus inactivation, which represents the first commercial scale combined unit operations in this space.

Process Economics of Continuous Downstream Bioprocessing

Biotech | Pall Corporation webinar series

Learn the findings of the full-factorial modeling exercise

Understand the cost benefits of continuous bioprocessing at many scales of manufacturing.

September 2017
Virus Filtration in Continuous Processing

Biotech | Pall Corporation webinar series

  • Learn how to implement Quality by Design (QbD) principles, and process validation strategies for continuous virus filtration
  • See the process inputs that should be evaluated to determine critical process parameters
  • Learn how a Pegasus™ Prime virus filter achieves high virus retention and delivers a robust and efficient continuous process